India · Delayed Price · Currency is INR Gufic Biosciences Statistics
Total Valuation
NSE:GUFICBIO has a market cap or net worth of INR 35.70 billion. The enterprise value is 38.99 billion.
| Market Cap | 35.70B |
| Enterprise Value | 38.99B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | Sep 22, 2025 |
Share Statistics
| Current Share Class | 100.28M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 43.31% |
| Owned by Institutions (%) | 6.69% |
| Float | 25.86M |
Valuation Ratios
The trailing PE ratio is 55.60.
| PE Ratio | 55.60 |
| Forward PE | n/a |
| PS Ratio | 3.78 |
| PB Ratio | 5.37 |
| P/TBV Ratio | 5.42 |
| P/FCF Ratio | 258.95 |
| P/OCF Ratio | 79.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.76, with an EV/FCF ratio of 282.78.
| EV / Earnings | 60.71 |
| EV / Sales | 4.13 |
| EV / EBITDA | 25.76 |
| EV / EBIT | 32.35 |
| EV / FCF | 282.78 |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.61.
| Current Ratio | 1.55 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 29.36 |
| Interest Coverage | 3.29 |
Financial Efficiency
Return on equity (ROE) is 10.14% and return on invested capital (ROIC) is 9.38%.
| Return on Equity (ROE) | 10.14% |
| Return on Assets (ROA) | 6.00% |
| Return on Invested Capital (ROIC) | 9.38% |
| Return on Capital Employed (ROCE) | 14.61% |
| Weighted Average Cost of Capital (WACC) | 4.41% |
| Revenue Per Employee | 6.36M |
| Profits Per Employee | 432,714 |
| Employee Count | 1,484 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.56 |
Taxes
In the past 12 months, NSE:GUFICBIO has paid 223.36 million in taxes.
| Income Tax | 223.36M |
| Effective Tax Rate | 25.81% |
Stock Price Statistics
The stock price has decreased by -2.18% in the last 52 weeks. The beta is -0.02, so NSE:GUFICBIO's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -2.18% |
| 50-Day Moving Average | 317.06 |
| 200-Day Moving Average | 325.77 |
| Relative Strength Index (RSI) | 55.64 |
| Average Volume (20 Days) | 197,080 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:GUFICBIO had revenue of INR 9.44 billion and earned 642.15 million in profits. Earnings per share was 6.40.
| Revenue | 9.44B |
| Gross Profit | 5.23B |
| Operating Income | 1.21B |
| Pretax Income | 865.49M |
| Net Income | 642.15M |
| EBITDA | 1.51B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | 6.40 |
Balance Sheet
The company has 762.17 million in cash and 4.05 billion in debt, with a net cash position of -3.29 billion.
| Cash & Cash Equivalents | 762.17M |
| Total Debt | 4.05B |
| Net Cash | -3.29B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.65B |
| Book Value Per Share | 66.20 |
| Working Capital | 2.84B |
Cash Flow
In the last 12 months, operating cash flow was 449.68 million and capital expenditures -311.81 million, giving a free cash flow of 137.87 million.
| Operating Cash Flow | 449.68M |
| Capital Expenditures | -311.81M |
| Depreciation & Amortization | 308.33M |
| Net Borrowing | 662.08M |
| Free Cash Flow | 137.87M |
| FCF Per Share | n/a |
Margins
Gross margin is 55.38%, with operating and profit margins of 12.77% and 6.80%.
| Gross Margin | 55.38% |
| Operating Margin | 12.77% |
| Pretax Margin | 9.17% |
| Profit Margin | 6.80% |
| EBITDA Margin | 16.03% |
| EBIT Margin | 12.77% |
| FCF Margin | 1.46% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.03%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1.56% |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 1.80% |
| FCF Yield | 0.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |